Biophytis

Biophytis SA, formerly Institut Biophytis Sas is a France-based company engaged in the healthcare industry. The Company is a biotechnology entity specialized in the development of drug candidates to treat ageing diseases. Its two programs relate to sarcopenia (loss of muscle functionality) and age-related muscular degeneration (Armd). Biophytis SA is engaged in the clinical and regulatory development of its drug candidates, such as Sarconeos (BIO101) and Macuneos (BIO201), simultaneously in the United States and domestic market.
Type
Public
HQ
Romainville, FR
Founded
2006
Employees
10 (est)
Biophytis was founded in 2006 and is headquartered in Romainville, FR

Biophytis Locations

Romainville, FR

Biophytis Metrics

Biophytis Summary

Market capitalization

€24.2 M

Closing share price

€3.94
Biophytis's current market capitalization is €24.2 M.

Biophytis Market Value History

Biophytis Online Presence

Biophytis Company Life